25 May 2013
Keywords: profits, up, aventis, 3rd, quarter, full-year, sales
Article | 10 November 2003
Franco-German drug major Aventis has reined-in its full-year salesforecast, citing a slowdown in the overall growth of the US pharmaceutical ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.